文献速递类风湿关节炎血管炎

冠状动脉周围脂肪组织作为类风湿关节炎冠状动脉粥样硬化及心血管风险生物标志物

Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究在150例类风湿关节炎(RA)患者中,通过基线及约6.9年后冠状动脉CT血管造影测量冠状动脉周围脂肪组织衰减(PCATa),评估其与冠状动脉粥样硬化负荷、进展及心血管风险的关系。结果显示平均及特定动脉PCATa与斑块数量、亚型范围、负荷及进展相关,且平均、LCx和RCA-PCATa与心血管事件相关,RCA-PCATa可优化风险预测。

要点

  • 平均及LAD、LCx、RCA的PCATa与基线总斑块数量及不同斑块亚型范围和负荷相关。
  • 平均及动脉特异性PCATa与总斑块、非钙化、低密度及钙化斑块的进展存在多样关联。
  • 平均、LCx和RCA-PCATa与心血管风险相关,RCA-PCATa阈值可提高风险预测准确性。

核心结论

  • 在RA患者中,平均及动脉特异性PCATa与冠状动脉斑块范围、负荷、成分及进展相关,并与心血管事件相关。
  • RCA-PCATa可优化超越粥样硬化的风险预测,提示其作为预测生物标志物的潜在效用。

研究设计与样本

  • 单中心观察性队列研究,纳入150例RA患者,进行基线及6.9±0.3年后的冠状动脉影像筛查与监测。
  • 测量左前降支(LAD)、左回旋支(LCx)和右冠状动脉(RCA)周围PCATa,计算粥样硬化节段数、斑块成分及绝对体积。

主要发现

  • 平均PCATa每增加1个标准差,总斑块数量的调整发病率比为1.21(95%CI 1.02-1.27)。
  • LCx-PCATa每增加1个标准差,总斑块数量的调整发病率比为1.20(95%CI 1.00-1.43)。
  • RCA-PCATa每增加1个标准差,总斑块数量的调整发病率比为1.22(95%CI 1.02-1.46)。
  • 平均PCATa每增加1个标准差,心血管风险的调整风险比为0.10(95%CI 0.02-0.56)。
  • LCx-PCATa每增加1个标准差,心血管风险的调整风险比为0.11(95%CI 0.03-0.43);RCA-PCATa为0.15(95%CI 0.04-0.53)。

临床怎么用

  • PCATa可作为RA患者冠状动脉粥样硬化负荷、进展及心血管风险的影像生物标志物。
  • RCA-PCATa阈值有助于优化RA患者心血管风险预测,辅助识别高危个体。

局限性

  • 单中心观察性队列设计,样本量150例,结果需多中心验证。
  • 原文未报告PCATa具体阈值数值及测量者间一致性等信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pericoronary adipose tissue attenuation (PCATa) on computed tomography angiography reflects coronary artery inflammation and associated with cardiovascular risk beyond atherosclerosis in general patients. We aimed to evaluate the relationships between PCATa and coronary atherosclerosis burden, progression and cardiovascular risk in rheumatoid arthritis (RA). METHODS: A total of 150 patients in a single-centre observational cohort underwent screening and surveillance coronary imaging 6.9 ±0.3 years later. PCATa around left anterior descending (LAD), left circumflex (LCx) and right coronary artery (RCA) were measured. Numbers of atherosclerotic segments (disease extent), plaque composition (noncalcified, low-density, mixed or calcified) and absolute volumes (mm3, plaque burden) were computed. RESULTS: Mean (adjusted incidence rate ratio 1.21 [95% confidence interval 1.02-1.27]), LCx (1.20 [1.00-1.43]) and RCA-PCATa (1.22 [1.02-1.46] per standard deviation (SD) increase) associated with total plaque numbers and variably with plaque subtype extent and burden at baseline. Mean and artery-specific PCATa exhibited diverse associations with total, noncalcified, low-density and calcified plaque progression. Using artery-specific PCATa thresholds, mean (adjusted hazards ratio 0.10 [95% CI 0.02-0.56]), LCx (0.11 [95% CI 0.03-0.43]) and RCA-PCATa (0.15 [0.04-0.53] per SD increase) were linked to cardiovascular risk. RCA-PCATa threshold in particular increased risk estimate accuracy (ΔAUC = 0.066 [bias-corrected 95% CI 0.024-0.126], P = 0.005). CONCLUSION: Mean and artery-specific PCATa associated with the extent, burden and composition of coronary plaque and its progression in RA. Mean, LCx and RCA-PCATa were linked to cardiovascular events, and RCA-PCATa specifically optimized risk estimates beyond atherosclerosis, highlighting its potential utility as a predictive biomarker.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Karpouzas GA, Cosedis Enevoldsen F, Rezaeian P, et al. Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford). 2026. PMID: 42033781. doi:10.1093/rheumatology/keag239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。